Charlie Haywood Bridges, MD | |
7777 Hennessy Blvd.,, Ste. 608, Baton Rouge, LA 70808 | |
(225) 767-0394 | |
(225) 767-3904 |
Full Name | Charlie Haywood Bridges |
---|---|
Gender | Male |
Speciality | Urology |
Experience | 50 Years |
Location | 7777 Hennessy Blvd.,, Baton Rouge, Louisiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1457386310 | NPI | - | NPPES |
110019921 | Other | LA | MEDICARE RAILROAD |
0691769 | Other | LA | AETNA |
1900032 | Other | LA | UNITED HEALTHCARE |
1370339 | Medicaid | LA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | 07141R (Louisiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Lallie Kemp Medical Center | Independence, LA | Hospital |
Our Lady Of The Lake Regional Medical Center | Baton rouge, LA | Hospital |
Baton Rouge General Medical Center | Baton rouge, LA | Hospital |
Entity Name | Capitol City Family Health Center Incorporated |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1265548614 PECOS PAC ID: 5193639151 Enrollment ID: O20051130000101 |
News Archive
Pompe disease, a severe glycogen storage disease appearing in Lapphunds is caused by a genetic defect in acid α-glucosidase gene. The same genetic mutation also causes the equivalent disease in humans. Based on this finding, canine Pompe disease can now be diagnosed with a genetic test.
UL (Underwriters Laboratories), a global safety science leader, announced today that UL Environment's Craig Rowlands, PhD, DABT, senior toxicologist, will serve as an advisory board member of Johns Hopkins Center for Alternatives to Animal Testing (CAAT) and UL Environment's Anne Bonhoff, PhD, global head of chemistry, will serve as an advisory board member of the European branch (CAAT-Europe) located at the University of Konstanz, Germany.
In late December, nearly two years after the epidemic began, the World Health Organization has declared the African country of Guinea to be free of Ebola virus infections. But, the race to find a cure and therapies to combat the disease are forging ahead as officials warn that inattention could lead to another epidemic.
CQ HealthBeat reports that at least one House lawmaker is pushing to move a bill that is considered the companion to the Blunt amendment, which would have expanded exemptions to the Obama administration rule and was defeated late last week by the full Senate.
Vertex Pharmaceuticals Incorporated announced today that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion by consensus recommending the approval of KALYDECO (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
› Verified 3 days ago
Entity Name | Charlie H Bridges Md, Facs |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1003135633 PECOS PAC ID: 0143351577 Enrollment ID: O20100629000838 |
News Archive
Pompe disease, a severe glycogen storage disease appearing in Lapphunds is caused by a genetic defect in acid α-glucosidase gene. The same genetic mutation also causes the equivalent disease in humans. Based on this finding, canine Pompe disease can now be diagnosed with a genetic test.
UL (Underwriters Laboratories), a global safety science leader, announced today that UL Environment's Craig Rowlands, PhD, DABT, senior toxicologist, will serve as an advisory board member of Johns Hopkins Center for Alternatives to Animal Testing (CAAT) and UL Environment's Anne Bonhoff, PhD, global head of chemistry, will serve as an advisory board member of the European branch (CAAT-Europe) located at the University of Konstanz, Germany.
In late December, nearly two years after the epidemic began, the World Health Organization has declared the African country of Guinea to be free of Ebola virus infections. But, the race to find a cure and therapies to combat the disease are forging ahead as officials warn that inattention could lead to another epidemic.
CQ HealthBeat reports that at least one House lawmaker is pushing to move a bill that is considered the companion to the Blunt amendment, which would have expanded exemptions to the Obama administration rule and was defeated late last week by the full Senate.
Vertex Pharmaceuticals Incorporated announced today that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion by consensus recommending the approval of KALYDECO (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Charlie Haywood Bridges, MD 7777 Hennessy Blvd.,, Ste. 608, Baton Rouge, LA 70808 Ph: (225) 767-0394 | Charlie Haywood Bridges, MD 7777 Hennessy Blvd.,, Ste. 608, Baton Rouge, LA 70808 Ph: (225) 767-0394 |
News Archive
Pompe disease, a severe glycogen storage disease appearing in Lapphunds is caused by a genetic defect in acid α-glucosidase gene. The same genetic mutation also causes the equivalent disease in humans. Based on this finding, canine Pompe disease can now be diagnosed with a genetic test.
UL (Underwriters Laboratories), a global safety science leader, announced today that UL Environment's Craig Rowlands, PhD, DABT, senior toxicologist, will serve as an advisory board member of Johns Hopkins Center for Alternatives to Animal Testing (CAAT) and UL Environment's Anne Bonhoff, PhD, global head of chemistry, will serve as an advisory board member of the European branch (CAAT-Europe) located at the University of Konstanz, Germany.
In late December, nearly two years after the epidemic began, the World Health Organization has declared the African country of Guinea to be free of Ebola virus infections. But, the race to find a cure and therapies to combat the disease are forging ahead as officials warn that inattention could lead to another epidemic.
CQ HealthBeat reports that at least one House lawmaker is pushing to move a bill that is considered the companion to the Blunt amendment, which would have expanded exemptions to the Obama administration rule and was defeated late last week by the full Senate.
Vertex Pharmaceuticals Incorporated announced today that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion by consensus recommending the approval of KALYDECO (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
› Verified 3 days ago
Dr. Jason Peary Bridges, Urology Medicare: Accepting Medicare Assignments Practice Location: 7777 Hennessy Blvd Ste 608, Baton Rouge, LA 70808 Phone: 225-767-0394 Fax: 225-767-3904 | |
Robert Stewart Taylor, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 8080 Bluebonnet Blvd, Ste 3000, Baton Rouge, LA 70810 Phone: 225-766-8100 Fax: 225-769-5596 | |
Dr. Kenneth Mciver Blue Jr., MD Urology Medicare: Not Enrolled in Medicare Practice Location: 8080 Bluebonnet Blvd, Ste 3000, Baton Rouge, LA 70810 Phone: 225-766-8100 Fax: 225-766-3240 | |
James Selser Morris, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 7777 Hennessy Blvd, Suite 2004, Baton Rouge, LA 70808 Phone: 225-769-2500 Fax: 225-769-9424 | |
Harold David Wexler, Urology Medicare: Not Enrolled in Medicare Practice Location: 8080 Bluebonnet Blvd, Ste 3000, Baton Rouge, LA 70810 Phone: 225-766-8100 Fax: 225-408-6867 | |
Dr. Kenneth Mciver Blue Iii, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 8080 Bluebonnet Blvd, Suite 3000, Baton Rouge, LA 70810 Phone: 225-766-8100 Fax: 225-408-6896 | |
Sujith K Reddy, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 16777 Medical Center Dr, Baton Rouge, LA 70816 Phone: 225-754-3278 Fax: 225-754-5090 |